Change of intestinal mucosa barrier function in the progress of non-alcoholic steatohepatitis in rats

World Journal of Gastroenterology

Volumn 14, Issue 20, 2008, Pages 3254-3258

  Li, Sheng ^a   Wu, Wan Chun ^a   He, Chi Yi ^a   Han, Zhen ^a   Jin, Dao You ^a   Wang, Lin ^a  

^a WANNAN MEDICAL COLLEGE   (China)

Author keywords

Endotoxin; Intestinal mucosa barrier; Non alcoholic steatohepatitis; Secretory IgA

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; ENDOTOXIN; EOSIN; HEMATOXYLIN; IMMUNOGLOBULIN A; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; XYLOSE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; INTESTINE MUCOSA PERMEABILITY; LIPID DIET; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; RAT; STAINING; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 48949100252     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.3254     Document Type: Article

References (31)

1. Day CP. Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? Gut 2002; 50:585-588
2. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80
3. Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003; 98: 2042-2047
4. Koruk M, Savas MC, Yilmaz O, Taysi S, Karakok M, Gundogdu C, Yilmaz A. Serum lipids, lipoproteins and apolipoproteins levels in patients with nonalcoholic steatohepatitis. J Clin Gastroenterol 2003; 37: 177-182
5. Baskol G, Baskol M, Kocer D. Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis. Clin Biochem 2007; 40: 776-780
6. Kojima H, Sakurai S, Uemura M, Fukui H, Morimoto H, Tamagawa Y. Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis. Alcohol Clin Exp Res 2007; 31: S61-S66
7. Mitsuyoshi H, Itoh Y, Okanoue T. [Role of oxidative stress in non-alcoholic steatohepatitis] Nippon Rinsho 2006; 64: 1077-1082
8. Leclercq IA. Pathogenesis of steatohepatitis: insights from the study of animal models. Acta Gastroenterol Belg 2007; 70: 25-31
9. Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2002; 17 Suppl: S186-S190
10. Choudhury J, Sanyal AJ. Insulin resistance in NASH. Front Biosci 2005; 10: 1520-1533
11. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001; 48: 206-211
12. Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palu G, Martines D. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007; 292: G518-G525
13. [Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases] Zhonghua Ganzangbing Zazhi 2006; 14: 161-163
14. Zhang YP, Shi ZR. Effects of probiotics on the bacterial groups of intestinal and sIgA in severely burned rats. Zhongguo Weishengwu Zazhi 2004; 5: 257-259
15. Kirsch R, Clarkson V, Verdonk RC, Marais AD, Shephard EG, Ryffel B, de la. M Hall P. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency. J Gastroenterol Hepatol 2006; 21: 174-182
16. Li X, Han de W, Zhao LF, Yin L. [Effect of Endotoxin on the expression of peroxisome proliferator-activated receptor alpha in the development of nonalcoholic steatohepatitis in rats] Zhonghua Ganzangbing Zazhi 2005; 13: 89-91
17. Fan JG, Xu ZJ, Wang GL, Ding XD, Tian LY, Zheng XY. [Change of serum endotoxin level in the progress of nonalcoholic steatohepatitis in rats] Zhonghua Ganzangbing Zazhi 2003; 11: 73-76
18. Baumgart DC, Dignass AU. Intestinal barrier function. Curr Opin Clin Nutr Metab Care 2002; 5: 685-694
19. Sakaguchi T, Brand S, Reinecker HC. Mucosal barrier and immune mediators. Curr Opin Gastroenterol 2001; 17: 573-577
20. Tlaskalova-Hogenova H, Farre-Castany MA, Stepankova R, Kozakova H, Tuckova L, Funda DP, Barot R, Cukrowska B, Sinkora J, Mandel L. The gut as a lymphoepithelial organ: the role of intestinal epithelial cells in mucosal immunity. Folia Microbiol (Praha) 1995; 40: 385-391
21. Sydora BC, Martin SM, Lupicki M, Dieleman LA, Doyle J, Walker JW, Fedorak RN. Bacterial antigens alone can influence intestinal barrier integrity, but live bacteria are required for initiation of intestinal inflammation and injury. Inflamm Bowel Dis 2006; 12: 429-436
22. Mazanec MB, Nedrud JG, Kaetzel CS, Lamm ME. A three-tiered view of the role of IgA in mucosal defense. ImmunolToday 1993; 14: 430-435
23. Takahashi I, Kiyono H. Gut as the largest immunologic tissue. JPEN J Parenter Enteral Nutr 1999; 23: S7-S12
24. Lamm ME. Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol 1997; 51: 311-340
25. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-845
26. Koruk M, Taysi S, Savas MC, Yilmaz O, Akcay F, Karakok M. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Ann Clin Lab Sci 2004; 34: 57-62
27. Baskol G, Baskol M, Kocer D. Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis. Clin Biochem 2007; 40: 776-780
28. Mercer DW, Smith GS, Cross JM, Russell DH, Chang L, Cacioppo J. Effects of lipopolysaccharide on intestinal injury; potential role of nitric oxide and lipid peroxidation. J Surg Res 1996; 63: 185-192
29. Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M, Wallace M. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol 2007; 47: 571-579
30. Tomita K, Tamiya G, Ando S, Ohsumi K, Chiyo T, Mizutani A, Kitamura N, Toda K, Kaneko T, Horie Y, Han JY, Kato S, Shimoda M, Oike Y, Ton-dzawa M, Makino S, Ohkura T, Saito H, Kumagai N, Nagata H, Ishii H, Hibi T. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 2006; 55: 415-424
31. Poniachik J, Csendes A, Diaz JC, Rojas J, Burdiles P, Maluenda F, Smok G, Rodrigo R, Videla LA. hicreased production of IL-1alpha. and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease. Cytokine 2006; 33: 252-257